-Gianni Bonadonna Researcher Activity Profile

Research Author Detailed Information 

Gianni Bonadonna Publication Rate By Year

Gianni Bonadonna has published 3 paper(s) in 1974, 2 paper(s) in 1976, 1 paper(s) in 1978, 5 paper(s) in 1979, 2 paper(s) in 1981, 2 paper(s) in 1982, 2 paper(s) in 1984, 4 paper(s) in 1985, 4 paper(s) in 1990, 3 paper(s) in 1993, 2 paper(s) in 1996, 1 paper(s) in 1997, 1 paper(s) in 1999, 3 paper(s) in 2008, for a total of 35 research publications in total.

Gianni G Bonadonna Author Information

LAST NAME: bonadonna

FIRST NAME: Gianni

INITIALS: g

AFFILIATION:

Papers

Gianni Bonadonna's Publication Record

1. Lessons from the initial adjuvant cyclophosphamide, methotrexate, and fluorouracil studies in operable breast cancer. Year Published: 2008
European Institute of Oncology, Milano, Italy.
2. Adjuvant combination chemotherapy in primary mammary carcinoma: the CMF program. Year Published: 1978
3. Pathological staging in adult previously untreated non-Hodgkin's lymphomas. Year Published: 1979
4. Adriamycin in the adjuvant treatment of operable osteosarcoma. Year Published: 1979
5. Adjuvant chemotherapy with nitrosourea compounds following surgery plus radiotherapy in glioblastoma multiforme. Year Published: 1979
6. Current results with a combined treatment approach to localized Ewing's sarcoma. Year Published: 1979
7. Combined modality management of operable breast cancer. Year Published: 1979
8. Preliminary clinical experience with 4-epidoxorubicin in advanced human neoplasia. Year Published: 1981
9. Adjuvant therapies of postsurgical minimal residual disease. Year Published: 1981
10. Multimodal therapy with CMF in resectable breast cancer with positive axillary nodes: the Milan Institute experience. Year Published: 1982
11. Clinical trials on adjuvant therapies in cancer: short-term and long-term results. Year Published: 1982
12. Relationship between estrogen receptors and CMF adjuvant chemotherapy. Year Published: 1984
13. New adjuvant trials for resectable breast cancer at the Istituto Nazionale Tumori of Milan. Year Published: 1984
14. Adjuvant programs for postmenopausal women with node-positive breast cancer: preliminary analysis of 5-year results. Year Published: 1985
15. Second malignant neoplasms in operable carcinoma of the breast. Year Published: 1985
16. Contribution of prognostic factors to adjuvant chemotherapy in breast cancer. Year Published: 1985
17. CMF adjuvant programs at the Milan Cancer Institute. Year Published: 1985
18. Hodgkin's disease: the Milan Cancer Institute experience with MOPP and ABVD. Year Published: 1990
Divisions of Medical Oncology, Istituto Nazionale Tumori, Milan, Italy.
19. The Milan experience with adjuvant chemotherapy in premenopausal breast cancer. Year Published: 1990
Istituto Nazionale Tumori, Milano, Italy.
20. Adjuvant chemotherapy for node-negative breast cancer patients. Year Published: 1990
Istituto Nazionale Tumori, Milano, Italy.
21. Salvage treatments in relapsing resectable breast cancer. Year Published: 1990
Istituto Nazionale Tumori, Milano, Italy.
22. Primary chemotherapy for resectable breast cancer. Year Published: 1993
Istituto Nazionale Tumori, Milan, Italy.
23. What did we learn from the results of the international overview about the effects of endocrine therapy? Year Published: 1993
Istituto Nazionale Tumori, Milan, Italy.
24. Long-term sequelae from adjuvant chemotherapy. Year Published: 1993
Istituto Nazionale Tumori, Milan, Italy.
25. Future developments in adjuvant systemic therapy for high-risk breast cancer. Year Published: 1996
Department of Cancer Medicine, Istituto Nazionale Tumori, Milan, Italy.
26. VIII. Women's health perception and breast cancer: issues of fertility, hormone substitution, and cancer prevention. Year Published: 1996
Division of Medical Oncology, Istituto Nazionale Tumori, Milano, Italy.
27. Primary chemotherapy in surgically resectable breast cancer: the experience of the Milan Cancer Institute. Year Published: 1997
Istituto Nazionale Tumori, Milan, Italy.
28. Putting taxanes to work in operable breast cancer: a search for selective indications from empirical studies. Year Published: 1999
Divisione di Oncologia Medica, Istituto Nazionale Tumori, Milan, Italy.
29. Lessons from the initial adjuvant cyclophosphamide, methotrexate, and fluorouracil studies in operable breast cancer. Year Published: 2008
European Institute of Oncology, Milano, Italy.
30. Laparoscopy and laparotomy in staging Hodgkin's and non-Hodgkin's lymphoma. Year Published: 1976
31. Methotrexate (NSC-740) and bleomycin (NSC-125066) in the treatment of advanced epidermoid carcinoma of the uterine cervix. Year Published: 1974
32. Combination chemotherapy with adriamycin (NSC-123127) in metastatic mammary carcinoma. Year Published: 1974
33. Response and survival of patients with metastatic neuroblastoma after combination chemotherapy with adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and vincristine (NSC-67574). Year Published: 1974
34. Methyl-CCNU (NSCU-95441) versus methyl-CCNU plus cyclophosphamide (NSC-26271) in advanced gastrointestinal cancer. Year Published: 1976
35. Lessons from the initial adjuvant cyclophosphamide, methotrexate, and fluorouracil studies in operable breast cancer. Year Published: 2008
Department of Medical Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori [corrected]